Swiss National Bank’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-49,400
| Closed | -$298K | – | 2467 |
|
|
2024
Q2 | $298K | Buy |
49,400
+5,200
| +12% | +$31.4K | ﹤0.01% | 2450 |
|
|
2024
Q1 | $493K | Buy |
+44,200
| New | +$493K | ﹤0.01% | 2453 |
|
|
2023
Q2 | – | Sell |
-39,500
| Closed | -$179K | – | 2606 |
|
|
2023
Q1 | $179K | Sell |
39,500
-3,500
| -8% | -$15.8K | ﹤0.01% | 2634 |
|
|
2022
Q4 | $485K | Hold |
43,000
| – | – | ﹤0.01% | 2580 |
|
|
2022
Q3 | $412K | Hold |
43,000
| – | – | ﹤0.01% | 2621 |
|
|
2022
Q2 | $348K | Buy |
43,000
+23,800
| +124% | +$193K | ﹤0.01% | 2692 |
|
|
2022
Q1 | $324K | Buy |
19,200
+1,500
| +8% | +$25.3K | ﹤0.01% | 2655 |
|
|
2021
Q4 | $380K | Hold |
17,700
| – | – | ﹤0.01% | 2698 |
|
|
2021
Q3 | $1.31M | Hold |
17,700
| – | – | ﹤0.01% | 2305 |
|
|
2021
Q2 | $968K | Sell |
17,700
-500
| -3% | -$27.3K | ﹤0.01% | 2493 |
|
|
2021
Q1 | $1.34M | Buy |
18,200
+1,500
| +9% | +$111K | ﹤0.01% | 2226 |
|
|
2020
Q4 | $1.44M | Buy |
+16,700
| New | +$1.44M | ﹤0.01% | 2106 |
|